Skip to main content

Effect of Lactobacillus brevis CD2 containing lozenges and plaque pH and cariogenic bacteria in diabetic children: a randomised clinical trial

  • 2020-10-21
  • Clinical Oral Investigations 25(1)
    • S. Lai
    • P. Lingström
    • M. Cagetti
    • F. Cocco
    • G. Meloni
    • M. Arrica
    • G. Campus


Objective: The short-term effect (60 days) of Lactobacillus brevis CD2 lozenges vs placebo on variables related to caries and gingivitis in type 1 diabetic children was evaluated.

Material and methods: Eight diabetics (4-14 years old) were assigned to two groups (n = 34 subjects each), probiotic lozenges and placebo. Stimulated saliva for microbiological analysis and plaque pH were assessed at baseline (t0), 30 days (t1), 60 days (t2) and in the follow-up period (90 days from baseline, t3). Gingival status was assessed at t0, t2 and t3. Two-way ANOVA assessed differences between groups.

Results: In the probiotic group, Streptococcus mutans bacterial density mean scores dropped from 3.11 ± 1.13 at baseline to 1.82 ± 0.72 (t2) and to 2.06 ± 0.56 (t3), while in the placebo group, the scores were 3.09 ± 0.8 (t0), 2.82 ± 0.47 (t2) and 3.11 ± 0.43 (t3) (p < 0.01). Lowest and maximum pH fall increased in the probiotic group, from 5.37 ± 0.41 at baseline to 5.49 ± 0.24 at t3 (p < 0.01) and from 1.20 ± 0.46 to 0.98 ± 0.29 (p = 0.02). Bleeding score decreased significantly in both groups, showing a statistically significant lower bleeding score at t2 in the probiotic group (25.6%, 95% CI 21.5-32.7 vs 29.5%, 95% CI 25.2-34.9, p = 0.02).

Conclusions: Lactobacillus brevis CD2 has shown to improve caries-related risk factors and gingival health in diabetic children.

Clinical relevance: Lactobacillus brevis CD2 might contribute to improved oral health in type 1 diabetic children.

Keywords: Caries; Children; Lactobacillus brevis CD2; Plaque pH; Probiotic; Salivary mutans streptococci.

Research Insights

SupplementHealth OutcomeEffect TypeEffect Size
Lactobacillus brevisReduced Gingival BleedingBeneficial
Lactobacillus brevisReduced Streptococcus Mutans DensityBeneficial
Lactobacillus brevis HA-112Increased Plaque pH LevelsBeneficial
Lactobacillus brevis HA-112Reduced Gingival BleedingBeneficial
Lactobacillus brevis HA-112Reduced Streptococcus Mutans DensityBeneficial
Lactobacillus brevis MAK11L82BImproved Plaque pH StabilityBeneficial
Lactobacillus brevis MAK11L82BReduced Gingival BleedingBeneficial
Lactobacillus brevis MAK11L82BReduced Streptococcus Mutans LevelsBeneficial

Pillser helps you make informed health decisions by providing comprehensive, unbiased information about supplements. This includes detailed research on supplement ingredients, their benefits, potential risks, and their overall efficacy. You can contribute by sharing your feedback and suggestions.

Send us an email at